First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trial-MedSci.cn

First-in-Human study of JNJ-55920839 in healthy volunteers and patients with systemic lupus erythematosus: a randomised placebo-controlled phase 1 trial

Jordan, J; Benson, J; Chatham, WW; Furie, RA; Stohl, W; Wei, JCC; Marciniak, S; Yao, ZL; Srivastava, B; Schreiter, J; Cesaroni, M; Orillion, A; Seridi, L; Chevrier, M

Chevrier, M (corresponding author), Janssen, Res & Dev, Spring House, PA 19477 USA.

LANCET RHEUMATOLOGY, 2020; 2 (10): E613

Abstract

Background Activation of the type I interferon (IFN) pathway is associated with systemic lupus erythematosus (SLE). We assessed the safety and tolerab......

Full Text Link